Bio Green Med Solution, Inc.
BGMS
$0.86
-$0.02-2.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 336.00K | 778.00K | 666.00K | 81.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 336.00K | 778.00K | 666.00K | 81.00K | -- |
| Cost of Revenue | 257.00K | 635.00K | 544.00K | 64.00K | -- |
| Gross Profit | 79.00K | 143.00K | 122.00K | 17.00K | -- |
| SG&A Expenses | 497.00K | 389.00K | 1.25M | 1.00M | 1.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 754.00K | 1.02M | 1.75M | 1.07M | 1.25M |
| Operating Income | -418.00K | -246.00K | -1.08M | -992.00K | -1.25M |
| Income Before Tax | -396.00K | -167.00K | -606.00K | -988.00K | -1.25M |
| Income Tax Expenses | 9.00K | 30.00K | 5.00K | -- | 2.00K |
| Earnings from Continuing Operations | -405.00K | -197.00K | -611.00K | -988.00K | -1.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -68.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -405.00K | -197.00K | -611.00K | -988.00K | -1.32M |
| EBIT | -418.00K | -246.00K | -1.08M | -992.00K | -1.25M |
| EBITDA | -418.00K | -245.00K | -1.08M | -992.00K | -1.25M |
| EPS Basic | -0.08 | -0.04 | -2.21 | -1.31 | -0.98 |
| Normalized Basic EPS | -0.04 | -0.02 | -0.08 | -0.32 | -0.57 |
| EPS Diluted | -0.08 | -0.04 | -2.21 | -1.31 | -0.98 |
| Normalized Diluted EPS | -0.04 | -0.02 | -0.08 | -0.32 | -0.57 |
| Average Basic Shares Outstanding | 5.60M | 5.46M | 4.61M | 1.91M | 1.36M |
| Average Diluted Shares Outstanding | 5.60M | 5.46M | 4.61M | 1.91M | 1.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -5.19% | -10.15% | -3.27% | 0.00% | -3.11% |